9/22/20 - Leaderboard - Pharma

Eptifibatide reduces the risk of acute cardiac ischemic events in patients with unstable angina who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).

Rate and Review PolyPeptide Laboratories

Rating: 0 - 0 reviews
Let users know what you would have wanted to know about this company.
Click on a star to rate this company
  Privacy Policy.
When writing a review, please adhere to the Review Guidelines.